Despite the anticipated benefits of intrathecal drug delivery, few specialists truly appreciate its potential. This underappreciation was the topic of discussion during a recent panel, “New Innovations in Targeted Drug Delivery,” at the 2024 American Society of Pain & Neuroscience (ASPN) annual conference.
Delivering drugs by oral or parenteral routes may be limited by the blood–brain barrier, which prevents macromolecules and other substances from reaching the central